Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
18 Feb 2025 |
MR04 |
Satisfaction of charge 116801520002 in full
|
|
|
28 Jan 2025 |
TM01 |
Termination of appointment of Joanne Parfrey as a director on 25 January 2025
|
|
|
28 Jan 2025 |
TM01 |
Termination of appointment of Michael James Murphy as a director on 25 January 2025
|
|
|
28 Jan 2025 |
TM01 |
Termination of appointment of Jason Alexander Mellad as a director on 25 January 2025
|
|
|
28 Jan 2025 |
TM01 |
Termination of appointment of Michael Leith Anstey as a director on 25 January 2025
|
|
|
28 Jan 2025 |
TM02 |
Termination of appointment of Daniel Edward Rooke as a secretary on 25 January 2025
|
|
|
28 Jan 2025 |
AP01 |
Appointment of Mr Andrew James Williamson as a director on 25 January 2025
|
|
|
28 Jan 2025 |
AP01 |
Appointment of Mr Robert Timothy Sprawson as a director on 25 January 2025
|
|
|
28 Jan 2025 |
AP01 |
Appointment of Mr Nicholas Bryn Richards as a director on 25 January 2025
|
|
|
28 Jan 2025 |
PSC05 |
Change of details for Cambridge Innovation Capital Ltd as a person with significant control on 25 January 2025
|
|
|
28 Jan 2025 |
PSC07 |
Cessation of Jonathan Simon Milner as a person with significant control on 25 January 2025
|
|
|
28 Jan 2025 |
PSC07 |
Cessation of Babraham Research Campus Ltd as a person with significant control on 25 January 2025
|
|
|
28 Jan 2025 |
AD01 |
Registered office address changed from C/O Milner Therapeutics Institute Jeffrey Cheah Biomedical Centre Puddicombe Way Cambridge Cambridgeshire CB2 0AW United Kingdom to 22 Station Road Cambridge CB1 2JD on 28 January 2025
|
|
|
20 Nov 2024 |
CS01 |
Confirmation statement made on 14 November 2024 with no updates
|
|
|
13 Nov 2024 |
AA |
Total exemption full accounts made up to 30 March 2024
|
|
|
15 Jan 2024 |
TM01 |
Termination of appointment of Ian Tomlinson as a director on 11 December 2023
|
|
|
14 Jan 2024 |
MA |
Memorandum and Articles of Association
|
|
|
14 Jan 2024 |
RESOLUTIONS |
Resolutions
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
18 Dec 2023 |
AA |
Total exemption full accounts made up to 30 March 2023
|
|
|
28 Nov 2023 |
CS01 |
Confirmation statement made on 14 November 2023 with updates
|
|
|
16 Nov 2023 |
PSC05 |
Change of details for Cambridge Innovation Capital Ltd as a person with significant control on 3 August 2020
|
|
|
15 Nov 2023 |
PSC05 |
Change of details for Cambridge Innovation Capital Plc as a person with significant control on 3 August 2020
|
|
|
15 Nov 2023 |
PSC05 |
Change of details for Babraham Bioscience Technologies Limited as a person with significant control on 16 July 2021
|
|
|
20 Sep 2023 |
MR04 |
Satisfaction of charge 116801520001 in full
|
|
|
18 Sep 2023 |
MR01 |
Registration of charge 116801520002, created on 8 September 2023
|
|